Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 48.10
-0.31 (-0.64%)
Aug 24, 2026, 3:04 PM CST
Intco Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,188 | 1,011 | 1,465 | 383 | 629.07 | 7,430 |
Depreciation & Amortization | 1,056 | 964.69 | 862.47 | 723.5 | 629.94 | 368.62 |
Other Amortization | 3.48 | 3.48 | 2.07 | 0.03 | 1.14 | 0.15 |
Loss (Gain) From Sale of Assets | -0.1 | 0.4 | -0.22 | -0.21 | -2.37 | -0.38 |
Asset Writedown & Restructuring Costs | 208.77 | -303.69 | 196.69 | 51.03 | 37.53 | 93.05 |
Loss (Gain) From Sale of Investments | -375.51 | -383.36 | -407.52 | -263.01 | -151.91 | -61.12 |
Other Operating Activities | 1,043 | 501.37 | -103.83 | 26.83 | -198.22 | 96.04 |
Change in Accounts Receivable | 60.27 | 107.53 | -1,103 | -606.63 | 195.71 | 185.55 |
Change in Inventory | -686.42 | -82.25 | -190.52 | -151.44 | 55.29 | -240.93 |
Change in Accounts Payable | 460.32 | 224.87 | 385.37 | 430.85 | -190.87 | -314.25 |
Change in Other Net Operating Assets | -103.35 | 37.48 | 9.63 | 8.15 | 6.01 | 43.38 |
Operating Cash Flow | 2,897 | 1,885 | 1,079 | 502.41 | 1,065 | 8,680 |
Operating Cash Flow Growth | 87.09% | 74.69% | 114.78% | -52.85% | -87.72% | 1.04% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -1,908 | -2,575 | -1,789 | -1,439 | -1,715 | -5,444 |
Sale of Property, Plant & Equipment | 111.99 | 112.53 | 2.54 | 16.81 | 67.28 | 5.58 |
Divestitures | - | - | - | - | - | 4.6 |
Investment in Securities | -7,627 | -9,380 | -2,336 | -2,638 | -297.13 | -2,325 |
Other Investing Activities | 482.37 | 390.42 | 255.13 | 83.86 | 78.45 | 28.48 |
Investing Cash Flow | -8,940 | -11,452 | -3,868 | -3,976 | -1,867 | -7,730 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Long-Term Debt Issued | - | 21,096 | 14,060 | 7,896 | 1,849 | 560.29 |
Long-Term Debt Repaid | - | -16,960 | -8,016 | -2,312 | -563.75 | -438.03 |
Net Debt Issued (Repaid) | 75.13 | 4,136 | 6,044 | 5,583 | 1,286 | 122.26 |
Issuance of Common Stock | 4.16 | 148.83 | - | - | 66.45 | - |
Repurchase of Common Stock | -78.17 | -78.17 | -25.83 | - | - | -1.41 |
Common Dividends Paid | -510 | -422.17 | -338.28 | -184.92 | -457.11 | -1,074 |
Other Financing Activities | 6,411 | 4,593 | -4,255 | -2,389 | -346.04 | 119.95 |
Financing Cash Flow | 5,903 | 8,378 | 1,425 | 3,009 | 549.05 | -833.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -512.34 | -306.41 | 59.85 | 67.05 | 271.8 | -41.77 |
Net Cash Flow | -652.97 | -1,495 | -1,304 | -397.43 | 19.69 | 74.8 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 989.2 | -689.72 | -710.37 | -936.28 | -649.76 | 3,236 |
Free Cash Flow Growth | - | - | - | - | - | -43.12% |
Free Cash Flow Margin | 8.30% | -6.95% | -7.46% | -13.53% | -9.82% | 19.93% |
Free Cash Flow Per Share | 1.52 | -1.07 | -1.10 | -1.42 | -0.98 | 4.79 |
Levered Free Cash Flow | 339.7 | -635.31 | -1,275 | -1,447 | -994.12 | -230.09 |
Unlevered Free Cash Flow | 570.42 | -404.59 | -1,082 | -1,367 | -976.33 | -219.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | - | -157.97 | -440.36 | -327.53 | -729.81 | -335.24 |
Change in Working Capital | -227.51 | 91.45 | -936.08 | -418.76 | 120.3 | 753.64 |